Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Minerva Neurosciences, Inc. Director's Dealing 2020

Jan 3, 2020

35086_dirs_2020-01-03_a878cb2a-14fd-4dea-9f48-31d7d1768582.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Minerva Neurosciences, Inc. (NERV)
CIK: 0001598646
Period of Report: 2019-12-31

Reporting Person: Luthringer Remy (Director, CEO)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2019-12-31 Employee Stock Option (right to buy) $7.11 A 95698 Acquired 2029-12-30 Common Stock (95698) Direct

Footnotes

F1: This option vests 25% on December 31, 2019 and then in quarterly installments over 3 years thereafter.